Treatment effect of aspirin for primary prevention does not differ according to baseline ASCVD risk.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 33075272.
- Also identified by DOI 10.7326/ACPJ202010200-039.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nudy M, Cooper J, Ghahramani M, et al. <b>Aspirin for primary atherosclerotic cardiovascular disease prevention as baseline risk increases: a meta-regression analysis.</b> Am J Med. 2020;133:1056-64. 32445718.
Medical subject headings
- Atherosclerosis
- Cardiovascular Diseases